Investor Relations

Stock Information.


View Detailed Stock Information

Latest News.

Multiple studies show Nu.Q® NETs test could predict sepsis patients at risk of deteriorating

Read Press Release

Volition to share new 'NETs in sepsis management' data insights at upcoming webinar

Read Press Release

Volition hosts NETs in sepsis management symposium at ESICM Lives 2024

Read Press Release

Volition Appoints Dr. Ethel Rubin as an Independent Director

Read Press Release

Volition Hosts KOL Roundtable on Sepsis

Read Press Release

VolitionRx Limited Announces Second Quarter 2024 Financial Results and Business Update

Read Press Release

VolitionRx Announces Pricing of up to $21.5 Million Registered Direct Offering

Read Press Release

VolitionRx Limited Schedules Second Quarter 2024 Earnings Conference Call and Business Update

Read Press Release

Volition appoints PharmaVentures for Capture PCR™ and oncology portfolio licensing

Read Press Release

Latest Financial Results.

Q2 2024

Quarter Ended Jun 30, 2024

Latest Event.

Volition Nu.Q® NETs Data Insights Webinar

Company Overview.

Volition is a multi-national epigenetics company focused on advancing the science of epigenetics. Volition is dedicated to saving lives and improving outcomes for people and animals with life-altering diseases through earlier detection, as well as disease and treatment monitoring.

Through its subsidiaries, Volition is developing and commercializing simple, easy to use, cost-effective blood tests to help diagnose and monitor a range of diseases, including some cancers and diseases associated with NETosis, such as sepsis. Early diagnosis and monitoring have the potential not only to prolong the life of patients, but also improve their quality of life.

Volition's research and development activities are centered in Belgium, with an innovation laboratory and office in the U.S. and additional offices in London and Singapore.

IR Contacts.

Corporate Office

VolitionRx Ltd
1489 West Warm Springs Road
Suite 110
Henderson, NV 89014
Phone: +1-646-650-1351
info@volition.com

Investor Relations

VolitionRx
Phone: +1-646-650-1351
investorrelations@volition.com

Edison Advisors
Soo Romanoff
Phone: +1-773-573-9779
sromanoff@edisongroup.com

Transfer Agent

VStock Transfer, LLC
18 Lafayette Place
Woodmere, NY 11598
Phone: +1-212-828-8436
F: +1-646-536-3179
info@vstocktransfer.com
https://www.vstocktransfer.com